Published on ŚCO Kielce (https://onkol.kielce.pl)

Strona główna > BUDGET IMPACT ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF PATIENTS WITH RESECTED DUKES' C COLON CANCER (CC) FROM POLISH PUBLIC PAYER'S AND PATIENT'S PERSPECTIVES

BUDGET IMPACT ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF PATIENTS WITH RESECTED DUKES' C COLON CANCER (CC) FROM POLISH PUBLIC PAYER'S AND PATIENT'S PERSPECTIVES [1]

Title: BUDGET IMPACT ANALYSIS OF CAPECITABINE IN ADJUVANT TREATMENT OF PATIENTS WITH RESECTED DUKES' C COLON CANCER (CC) FROM POLISH PUBLIC PAYER'S AND PATIENT'S PERSPECTIVES
Author(s): Oleszko, R.; Kawalec, P.; Drobniak, A.; et al.
Source: Value in Health Volume: 13 Issue: 7 Pages: A257 Published: 2010
Times Cited: 0

Nauka [2]
Source URL:https://onkol.kielce.pl/pl/nauka/budget-impact-analysis-capecitabine-adjuvant-treatment-patients-resected-dukes-c-colon-cancer

Links
[1] https://onkol.kielce.pl/pl/nauka/budget-impact-analysis-capecitabine-adjuvant-treatment-patients-resected-dukes-c-colon-cancer [2] https://onkol.kielce.pl/pl/sekcja/nauka